Answers are grounded in this paper and cite their sources.
Higher willingness-to-pay thresholds for severe diseases are implemented in countries to reflect societal concerns for an equitable distribution of resources. However, the estimates of severity are uncertain, patient populations are heterogeneous, and this can be accounted for with the severity-adjusted probability of being cost effective proposed in this study. The application to the Netherlands suggests that not adopting the new method could result in incorrect decisions in the reimbursement of new health technologies.
No takes yet. Share an insight, caveat, or question.
Versteegh et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: